annual current liabilities:
$731.68M+$78.03M(+11.94%)Summary
- As of today (May 29, 2025), SRPT annual total current liabilities is $731.68 million, with the most recent change of +$78.03 million (+11.94%) on December 31, 2024.
- During the last 3 years, SRPT annual current liabilities has risen by +$278.95 million (+61.61%).
- SRPT annual current liabilities is now at all-time high.
Performance
SRPT Current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly current liabilities:
$605.59M-$126.10M(-17.23%)Summary
- As of today (May 29, 2025), SRPT quarterly total current liabilities is $605.59 million, with the most recent change of -$126.10 million (-17.23%) on March 1, 2025.
- Over the past year, SRPT quarterly current liabilities has dropped by -$3.12 million (-0.51%).
- SRPT quarterly current liabilities is now -17.23% below its all-time high of $731.68 million, reached on December 31, 2024.
Performance
SRPT quarterly current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Current liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
SRPT Current liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +11.9% | -0.5% |
3 y3 years | +61.6% | +33.1% |
5 y5 years | +176.3% | +97.6% |
SRPT Current liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +61.6% | -17.2% | +34.4% |
5 y | 5-year | at high | +176.3% | -17.2% | +97.6% |
alltime | all time | at high | >+9999.0% | -17.2% | >+9999.0% |
SRPT Current liabilities History
Date | Annual | Quarterly |
---|---|---|
Mar 2025 | - | $605.59M(-17.2%) |
Dec 2024 | $731.68M(+11.9%) | $731.68M(+4.6%) |
Sep 2024 | - | $699.49M(+1.6%) |
Jun 2024 | - | $688.49M(+13.1%) |
Mar 2024 | - | $608.71M(-6.9%) |
Dec 2023 | $653.66M(+5.5%) | $653.66M(+45.0%) |
Sep 2023 | - | $450.74M(-9.6%) |
Jun 2023 | - | $498.65M(-7.1%) |
Mar 2023 | - | $536.88M(-13.4%) |
Dec 2022 | $619.60M(+36.9%) | $619.60M(+2.8%) |
Sep 2022 | - | $602.92M(+10.5%) |
Jun 2022 | - | $545.57M(+19.9%) |
Mar 2022 | - | $454.96M(+0.5%) |
Dec 2021 | $452.73M(+8.8%) | $452.73M(+21.2%) |
Sep 2021 | - | $373.44M(-12.1%) |
Jun 2021 | - | $425.02M(+16.5%) |
Mar 2021 | - | $364.74M(-12.3%) |
Dec 2020 | $416.03M(+57.1%) | $416.03M(+9.9%) |
Sep 2020 | - | $378.39M(+6.6%) |
Jun 2020 | - | $354.90M(+15.8%) |
Mar 2020 | - | $306.43M(+15.7%) |
Dec 2019 | $264.77M(+52.4%) | $264.77M(+22.7%) |
Sep 2019 | - | $215.86M(+33.2%) |
Jun 2019 | - | $162.09M(+18.0%) |
Mar 2019 | - | $137.37M(-20.9%) |
Dec 2018 | $173.69M(+96.6%) | $173.69M(+51.8%) |
Sep 2018 | - | $114.39M(+9.3%) |
Jun 2018 | - | $104.69M(+14.8%) |
Mar 2018 | - | $91.20M(+3.2%) |
Dec 2017 | $88.33M(+17.1%) | $88.33M(+25.3%) |
Sep 2017 | - | $70.47M(+6.8%) |
Jun 2017 | - | $65.96M(-11.6%) |
Mar 2017 | - | $74.63M(-1.1%) |
Dec 2016 | $75.42M(+21.1%) | $75.42M(+16.2%) |
Sep 2016 | - | $64.93M(-3.0%) |
Jun 2016 | - | $66.93M(+21.3%) |
Mar 2016 | - | $55.16M(-11.5%) |
Dec 2015 | $62.29M(+69.0%) | $62.29M(+65.4%) |
Sep 2015 | - | $37.67M(-3.3%) |
Jun 2015 | - | $38.96M(+14.9%) |
Mar 2015 | - | $33.91M(-8.0%) |
Dec 2014 | $36.87M(+2.5%) | $36.87M(+62.2%) |
Sep 2014 | - | $22.73M(-22.7%) |
Jun 2014 | - | $29.40M(-22.1%) |
Mar 2014 | - | $37.76M(+5.0%) |
Dec 2013 | $35.97M(-54.4%) | $35.97M(-29.6%) |
Sep 2013 | - | $51.10M(-44.7%) |
Jun 2013 | - | $92.43M(-10.8%) |
Mar 2013 | - | $103.66M(+31.4%) |
Dec 2012 | $78.89M(+282.9%) | $78.89M(+42.9%) |
Sep 2012 | - | $55.20M(+222.2%) |
Jun 2012 | - | $17.13M(-42.7%) |
Mar 2012 | - | $29.92M(+45.3%) |
Dec 2011 | $20.60M(-55.1%) | $20.60M(-22.4%) |
Sep 2011 | - | $26.53M(-28.2%) |
Jun 2011 | - | $36.94M(-14.5%) |
Mar 2011 | - | $43.22M(-5.8%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2010 | $45.86M(+36.9%) | $45.86M(+4.8%) |
Sep 2010 | - | $43.77M(+17.4%) |
Jun 2010 | - | $37.27M(+41.5%) |
Mar 2010 | - | $26.34M(-21.4%) |
Dec 2009 | $33.51M(+359.8%) | $33.51M(-22.2%) |
Sep 2009 | - | $43.06M(+63.8%) |
Jun 2009 | - | $26.29M(+126.3%) |
Mar 2009 | - | $11.62M(+59.4%) |
Dec 2008 | $7.29M(-25.3%) | $7.29M(-31.7%) |
Sep 2008 | - | $10.67M(+20.8%) |
Jun 2008 | - | $8.83M(-27.3%) |
Mar 2008 | - | $12.14M(+24.5%) |
Dec 2007 | $9.75M(+209.5%) | $9.75M(+2.1%) |
Sep 2007 | - | $9.55M(+95.4%) |
Jun 2007 | - | $4.89M(+12.4%) |
Mar 2007 | - | $4.35M(+38.0%) |
Dec 2006 | $3.15M(+14.7%) | $3.15M(+44.3%) |
Sep 2006 | - | $2.18M(-3.6%) |
Jun 2006 | - | $2.26M(+2.5%) |
Mar 2006 | - | $2.21M(-19.6%) |
Dec 2005 | $2.75M(+22.2%) | $2.75M(+8.9%) |
Sep 2005 | - | $2.52M(+30.9%) |
Jun 2005 | - | $1.93M(-15.4%) |
Mar 2005 | - | $2.28M(+1.3%) |
Dec 2004 | $2.25M(-40.0%) | $2.25M(+66.7%) |
Sep 2004 | - | $1.35M(-37.7%) |
Jun 2004 | - | $2.17M(-21.2%) |
Mar 2004 | - | $2.75M(-26.7%) |
Dec 2003 | $3.75M(-26.8%) | $3.75M(+62.5%) |
Sep 2003 | - | $2.31M(+78.1%) |
Jun 2003 | - | $1.30M(-20.0%) |
Mar 2003 | - | $1.62M(-68.4%) |
Dec 2002 | $5.12M(+56.1%) | $5.12M(+4.2%) |
Sep 2002 | - | $4.92M(+24.3%) |
Jun 2002 | - | $3.96M(-16.2%) |
Mar 2002 | - | $4.72M(+43.9%) |
Dec 2001 | $3.28M(+90.5%) | $3.28M(+107.5%) |
Sep 2001 | - | $1.58M(-2.0%) |
Jun 2001 | - | $1.61M(-0.2%) |
Mar 2001 | - | $1.62M(-6.1%) |
Dec 2000 | $1.72M(+72.3%) | $1.72M(+30.9%) |
Sep 2000 | - | $1.32M(+19.2%) |
Jun 2000 | - | $1.10M(+44.0%) |
Mar 2000 | - | $767.00K(-23.3%) |
Dec 1999 | $1.00M(-16.7%) | $1.00M(+25.0%) |
Sep 1999 | - | $800.00K(+100.0%) |
Jun 1999 | - | $400.00K(-42.9%) |
Mar 1999 | - | $700.00K(-41.7%) |
Dec 1998 | $1.20M(+140.0%) | $1.20M(0.0%) |
Sep 1998 | - | $1.20M(+200.0%) |
Jun 1998 | - | $400.00K(-20.0%) |
Mar 1998 | - | $500.00K(0.0%) |
Dec 1997 | $500.00K(+66.7%) | $500.00K(-37.5%) |
Sep 1997 | - | $800.00K(-11.1%) |
Jun 1997 | - | $900.00K(+125.0%) |
Mar 1997 | - | $400.00K |
Dec 1996 | $300.00K | - |
FAQ
- What is Sarepta Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Sarepta Therapeutics?
- What is Sarepta Therapeutics annual current liabilities year-on-year change?
- What is Sarepta Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Sarepta Therapeutics?
- What is Sarepta Therapeutics quarterly current liabilities year-on-year change?
What is Sarepta Therapeutics annual total current liabilities?
The current annual current liabilities of SRPT is $731.68M
What is the all time high annual current liabilities for Sarepta Therapeutics?
Sarepta Therapeutics all-time high annual total current liabilities is $731.68M
What is Sarepta Therapeutics annual current liabilities year-on-year change?
Over the past year, SRPT annual total current liabilities has changed by +$78.03M (+11.94%)
What is Sarepta Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of SRPT is $605.59M
What is the all time high quarterly current liabilities for Sarepta Therapeutics?
Sarepta Therapeutics all-time high quarterly total current liabilities is $731.68M
What is Sarepta Therapeutics quarterly current liabilities year-on-year change?
Over the past year, SRPT quarterly total current liabilities has changed by -$3.12M (-0.51%)